• Citer

Comparison of sirolimus alone with sirolimus plus tacrolimus in type 1 diabetic recipients of cultured islet cell grafts.

par Gillard, Pieter;Ling, Zhidong;Mathieu, Chantal;Crenier, Laurent ;Lannoo, Matthias;Maes, Bart;Roep, Bart;Gorus, Frans;Pipeleers, Daniel;Keymeulen, Bart
Référence Transplantation, 85, 2, page (256-263)
Publication Publié, 2008-01

Article révisé par les pairs

• Détails
• Contenu

Titre:	Comparison of sirolimus alone with sirolimus plus tacrolimus in type 1 diabetic recipients of cultured islet cell grafts.
Auteur:	Gillard, Pieter; Ling, Zhidong; Mathieu, Chantal; Crenier, Laurent; Lannoo, Matthias; Maes, Bart; Roep, Bart; Gorus, Frans; Pipeleers, Daniel; Keymeulen, Bart
Informations sur la publication:	Transplantation, 85, 2, page (256-263)
Statut de publication:	Publié, 2008-01
Sujet CREF:	Transplantation d'organes
	Diabétologie
	Allergie et immunopathologie
Mots-clés:	Islet transplantation
	Sirolimus
	Tacrolimus
	Type 1 diabetes
MeSH keywords:	Adult
	Albuminuria -- epidemiology
	Autoantibodies -- blood
	C-Peptide -- blood
	Cell Transplantation -- adverse effects -- methods
	Diabetes Mellitus, Type 1 -- surgery
	Drug Therapy, Combination
	Female
	Graft Survival -- immunology
	Humans
	Immunosuppressive Agents -- therapeutic use
	Islets of Langerhans -- cytology -- immunology
	Islets of Langerhans Transplantation -- adverse effects -- immunology
	Lymphocyte Count
	Male
	Middle Aged
	Postoperative Complications -- pathology
	Sirolimus -- therapeutic use
	Tacrolimus -- therapeutic use
Note générale:	Clinical Trial
	Comparative Study
	Journal Article
	Research Support, Non-U.S. Gov't
	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0041-1337
	info:doi/10.1097/TP.0b013e31815e8926
	info:pii/00007890-200801270-00014
	info:scp/38549143599
	info:pmid/18212631